Rare Diseases Treatment Market Size, Share & Trends Analysis Report By Therapeutic Area (Cancer, Musculoskeletal Conditions), By Route of Administration, By Drug Type, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 4 Business Days
Rare Diseases Treatment Market Growth & Trends
The global rare diseases treatment market size is expected to reach USD 335.84 billion by 2030, according to a new study by Grand View Research Inc., expanding at a CAGR of 12.8% from 2022 to 2030. Increasing prevalence of rare diseases contributes to industry growth. According to the National Center for Advancing Translational Sciences (NCATS), over 30 million of the U.S. population is estimated to be affected by rare diseases in 2022. Increasing prevalence of people living with orphan diseases is anticipated to increase the sales and demand for orphan medicines over the forecast period.
The presence of supportive regulations by government authorities, such as the Orphan Drug Act that support product development by offering the orphan drug designation to potential drug candidates developed by pharmaceutical companies, is expected to support industry growth. This initiative boosts the research and development in the field of orphan disease treatment.
In April 2020, the National Organization for Rare Disorders (NORD) launched the “COVID-19 critical relief” program for patients with rare diseases affected by the COVID-19 pandemic. Under this program, the NORD provided monetary assistance of up to USD 1,000 annually to orphan disease patients and their caregivers for fulfilling their medical and non-medical needs. Thus, the availability of such programs is anticipated to boost the adoption of rare disease treatment over the forecast period.
Moreover, companies have undertaken initiatives such as collaborations and partnerships for the development, manufacturing, and commercialization of products in the international market. For instance, in August 2020, Sarepta Therapeutics, Inc. entered into a collaboration with the University of Florida for the development of novel genetic medicines for the treatment of patients with various orphan diseases, including Duchenne Muscular Dystrophy (DMD).
However, a lack of accurate and early diagnosis of rare diseases can often present a challenge for orphan disease patients, and in some cases, an accurate diagnosis is not obtained for as long as five years. In addition, patient eligibility and recruitment of eligible patients for clinical trials for rare disease treatment may restrain the industry growth. Not only finding the target population is difficult but finding physicians who treat these patients is also complex, thus leading to delays in the new product approval and launch in the market.
Rare Diseases Treatment Market Report Highlights
Rare Diseases Treatment Market Growth & Trends
The global rare diseases treatment market size is expected to reach USD 335.84 billion by 2030, according to a new study by Grand View Research Inc., expanding at a CAGR of 12.8% from 2022 to 2030. Increasing prevalence of rare diseases contributes to industry growth. According to the National Center for Advancing Translational Sciences (NCATS), over 30 million of the U.S. population is estimated to be affected by rare diseases in 2022. Increasing prevalence of people living with orphan diseases is anticipated to increase the sales and demand for orphan medicines over the forecast period.
The presence of supportive regulations by government authorities, such as the Orphan Drug Act that support product development by offering the orphan drug designation to potential drug candidates developed by pharmaceutical companies, is expected to support industry growth. This initiative boosts the research and development in the field of orphan disease treatment.
In April 2020, the National Organization for Rare Disorders (NORD) launched the “COVID-19 critical relief” program for patients with rare diseases affected by the COVID-19 pandemic. Under this program, the NORD provided monetary assistance of up to USD 1,000 annually to orphan disease patients and their caregivers for fulfilling their medical and non-medical needs. Thus, the availability of such programs is anticipated to boost the adoption of rare disease treatment over the forecast period.
Moreover, companies have undertaken initiatives such as collaborations and partnerships for the development, manufacturing, and commercialization of products in the international market. For instance, in August 2020, Sarepta Therapeutics, Inc. entered into a collaboration with the University of Florida for the development of novel genetic medicines for the treatment of patients with various orphan diseases, including Duchenne Muscular Dystrophy (DMD).
However, a lack of accurate and early diagnosis of rare diseases can often present a challenge for orphan disease patients, and in some cases, an accurate diagnosis is not obtained for as long as five years. In addition, patient eligibility and recruitment of eligible patients for clinical trials for rare disease treatment may restrain the industry growth. Not only finding the target population is difficult but finding physicians who treat these patients is also complex, thus leading to delays in the new product approval and launch in the market.
Rare Diseases Treatment Market Report Highlights
- By therapeutic area, cancer segment held the largest revenue share in 2021 due to high prevalence of cancer indications such as multiple myeloma, acute lymphoblastic leukemia, chronic myeloid leukemia, and esophageal cancer and wide availability of orphan drugs for the treatment of patients with these conditions
- By route of administration, the injectable segment dominated the market in 2021 and is expected to witness significant growth owing to high safety, efficacy, and tolerability associated with this route of administration among rare disease patients
- By drug type, the biologics segment dominated the market in 2021 due to the presence of supportive reimbursement policies and the higher efficacy of biologics as disease-modifying therapies for the treatment of rare diseases
- By distribution channel, the specialty pharmacy segment dominated the market in 2021 due to government initiatives to support specialty pharmacies that provide orphan drugs. For instance, in July 2022, Utilization Review Accreditation Commission (URAC) awarded Maxor Specialty Pharmacy with the rare diseases pharmacy center of excellence for providing high-quality orphan drugs to patients
- Asia Pacific is expected to witness lucrative growth during the forecast period. The growth of the region can be attributed to the entry of new products into the region. According to Illness Challenged Foundation, China had approved new 87 orphan drugs for 47 rare diseases by the end of 2021
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market segmentation
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.6 List of primary sources
1.4 Information or data analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.11.3 Objective
1.11.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.2 Market restraint analysis
3.6 PESTEL Analysis
CHAPTER 4 GLOBAL RARE DISEASES TREATMENT MARKET - SEGMENT ANALYSIS, BY THERAPEUTIC AREA, 2018 - 2030 (USD MILLION)
4.1 Global Rare Diseases Treatment Market: Therapeutic Area Movement Analysis
4.2 Cancer
4.2.1 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
4.3 Neurological Conditions
4.3.1 Neurological conditions market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Cardiovascular Conditions
4.4.1 Cardiovascular conditions market estimates and forecast, 2018 - 2030 (USD Million)
4.5 Musculoskeletal Conditions
4.5.1 Musculoskeletal conditions market estimates and forecast, 2018 - 2030 (USD Million)
4.6 Hematologic Disorders
4.6.1 Hematologic disorders market estimates and forecast, 2018 - 2030 (USD Million)
4.7 Infectious Diseases
4.7.1 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
4.8 Metabolic Disorders
4.8.1 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
4.9 Endocrine Disorders
4.9.1 Endocrine disorders market estimates and forecast, 2018 - 2030 (USD Million)
4.10 Others
4.10.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5 GLOBAL RARE DISEASES TREATMENT MARKET - SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)
5.1 Global Rare Diseases Treatment Market: Route of Administration Movement Analysis
5.2 Oral
5.2.1 Oral market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Injectable
5.3.1 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 GLOBAL RARE DISEASES TREATMENT MARKET - SEGMENT ANALYSIS, BY DRUGTYPE, 2018 - 2030 (USD MILLION)
6.1 Global Rare Diseases Treatment Market: Drug TypeMovement Analysis
6.2 Biologics
6.2.1 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Biosimilars
6.3.1 Biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Small Molecule
6.4.1 Small Molecule market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7 GLOBAL RARE DISEASES TREATMENT MARKET - SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
7.1 Global Rare Diseases Treatment Market: Distribution Channel Movement Analysis
7.2 Hospital Pharmacy
7.2.1 Hospital Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Specialty Pharmacy
7.3.1 Specialty Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Online Pharmacy
7.4.1 Online Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 RARE DISEASES TREATMENT MARKET: SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Rare Diseases Treatment Market: Regional Movement Analysis
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.2 U.K.
8.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.5 Spain
8.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.6 Italy
8.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.3 China
8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.4 India
8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 Australia
8.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 South Korea
8.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5 Middle East & Africa
8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.5 United Arab Emirates
8.1.5.5.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 GLOBAL RARE DISEASES TREATMENT MARKET: COMPETITIVE ANALYSIS
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.1.1 Major deals & strategic alliances analysis
9.1.1.1 New Product Launches
9.1.1.2 Mergers and Acquisitions
9.1.1.3 Partnerships & Agreements
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
9.4.1 List of Key Distributors and Channel Partners
9.4.2 List of Potential End-Users
9.4.3 Key Company Market Share Analysis, 2021
9.5 Company Market Share, 2021
9.5.1 Competitive Dashboard Analysis
9.6 Private Companies
9.6.1 List of Key Emerging Companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 F. Hoffmann-La Roche Ltd.
9.7.1.1 Company overview
9.7.1.2 Financial performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 Pfizer, Inc.
9.7.2.1 Company overview
9.7.2.2 Financial performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 PTC Therapeutics
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic initiatives
9.7.4 AstraZeneca
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 Novartis AG
9.7.5.1 Company overview
9.7.5.2 Financial performance
9.7.5.3 Product benchmarking
9.7.5.4 Strategic initiatives
9.7.6 Novo Nordisk
9.7.6.1 Company overview
9.7.6.2 Product benchmarking
9.7.6.3 Strategic initiatives
9.7.7 Takeda Pharmaceutical Company
9.7.7.1 Company overview
9.7.7.2 Financial performance
9.7.7.3 Product benchmarking
9.7.8 Bayer AG
9.7.8.1 Company overview
9.7.8.2 Financial performance
9.7.8.3 Product benchmarking
9.7.8.4 Strategic initiatives
9.7.9 Merck & Co., Inc.
9.7.9.1 Company overview
9.7.9.2 Financial performance
9.7.9.3 Product benchmarking
9.7.9.4 Strategic initiatives
9.7.10 Bristol Myers Squibb
9.7.10.1 Company overview
9.7.10.2 Financial performance
9.7.10.3 Product benchmarking
9.7.10.4 Strategic initiatives
1.1 Market segmentation
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.6 List of primary sources
1.4 Information or data analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.11.3 Objective
1.11.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.2 Market restraint analysis
3.6 PESTEL Analysis
CHAPTER 4 GLOBAL RARE DISEASES TREATMENT MARKET - SEGMENT ANALYSIS, BY THERAPEUTIC AREA, 2018 - 2030 (USD MILLION)
4.1 Global Rare Diseases Treatment Market: Therapeutic Area Movement Analysis
4.2 Cancer
4.2.1 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
4.3 Neurological Conditions
4.3.1 Neurological conditions market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Cardiovascular Conditions
4.4.1 Cardiovascular conditions market estimates and forecast, 2018 - 2030 (USD Million)
4.5 Musculoskeletal Conditions
4.5.1 Musculoskeletal conditions market estimates and forecast, 2018 - 2030 (USD Million)
4.6 Hematologic Disorders
4.6.1 Hematologic disorders market estimates and forecast, 2018 - 2030 (USD Million)
4.7 Infectious Diseases
4.7.1 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
4.8 Metabolic Disorders
4.8.1 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
4.9 Endocrine Disorders
4.9.1 Endocrine disorders market estimates and forecast, 2018 - 2030 (USD Million)
4.10 Others
4.10.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5 GLOBAL RARE DISEASES TREATMENT MARKET - SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)
5.1 Global Rare Diseases Treatment Market: Route of Administration Movement Analysis
5.2 Oral
5.2.1 Oral market estimates and forecast, 2018 - 2030 (USD Million)
5.3 Injectable
5.3.1 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6 GLOBAL RARE DISEASES TREATMENT MARKET - SEGMENT ANALYSIS, BY DRUGTYPE, 2018 - 2030 (USD MILLION)
6.1 Global Rare Diseases Treatment Market: Drug TypeMovement Analysis
6.2 Biologics
6.2.1 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Biosimilars
6.3.1 Biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Small Molecule
6.4.1 Small Molecule market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7 GLOBAL RARE DISEASES TREATMENT MARKET - SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
7.1 Global Rare Diseases Treatment Market: Distribution Channel Movement Analysis
7.2 Hospital Pharmacy
7.2.1 Hospital Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Specialty Pharmacy
7.3.1 Specialty Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Online Pharmacy
7.4.1 Online Pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 RARE DISEASES TREATMENT MARKET: SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Rare Diseases Treatment Market: Regional Movement Analysis
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.2 U.K.
8.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.5 Spain
8.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.6 Italy
8.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.3 China
8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.4 India
8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 Australia
8.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 South Korea
8.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5 Middle East & Africa
8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.5 United Arab Emirates
8.1.5.5.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 GLOBAL RARE DISEASES TREATMENT MARKET: COMPETITIVE ANALYSIS
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.1.1 Major deals & strategic alliances analysis
9.1.1.1 New Product Launches
9.1.1.2 Mergers and Acquisitions
9.1.1.3 Partnerships & Agreements
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
9.4.1 List of Key Distributors and Channel Partners
9.4.2 List of Potential End-Users
9.4.3 Key Company Market Share Analysis, 2021
9.5 Company Market Share, 2021
9.5.1 Competitive Dashboard Analysis
9.6 Private Companies
9.6.1 List of Key Emerging Companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 F. Hoffmann-La Roche Ltd.
9.7.1.1 Company overview
9.7.1.2 Financial performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 Pfizer, Inc.
9.7.2.1 Company overview
9.7.2.2 Financial performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 PTC Therapeutics
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic initiatives
9.7.4 AstraZeneca
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 Novartis AG
9.7.5.1 Company overview
9.7.5.2 Financial performance
9.7.5.3 Product benchmarking
9.7.5.4 Strategic initiatives
9.7.6 Novo Nordisk
9.7.6.1 Company overview
9.7.6.2 Product benchmarking
9.7.6.3 Strategic initiatives
9.7.7 Takeda Pharmaceutical Company
9.7.7.1 Company overview
9.7.7.2 Financial performance
9.7.7.3 Product benchmarking
9.7.8 Bayer AG
9.7.8.1 Company overview
9.7.8.2 Financial performance
9.7.8.3 Product benchmarking
9.7.8.4 Strategic initiatives
9.7.9 Merck & Co., Inc.
9.7.9.1 Company overview
9.7.9.2 Financial performance
9.7.9.3 Product benchmarking
9.7.9.4 Strategic initiatives
9.7.10 Bristol Myers Squibb
9.7.10.1 Company overview
9.7.10.2 Financial performance
9.7.10.3 Product benchmarking
9.7.10.4 Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Rare Diseases Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 5 Global Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 6 Global Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 7 Global Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 8 North America Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 9 North America Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 10 North America Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 11 North America Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 13 U.S. Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 14 U.S. Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 15 U.S. Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Canada Rare Diseases TreatmentMarket, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 17 Canada Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 18 Canada Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 19 Canada Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Europe Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 21 Europe Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 22 Europe Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 23 Europe Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Germany Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 25 Germany Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 26 Germany Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 27 Germany Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 U.K. Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 29 U.K. Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 30 U.K. Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 31 U.K. Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 France Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 33 France Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 34 France Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 35 France Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Italy Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 37 Italy Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 38 Italy Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 39 Italy Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Spain Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 41 Spain Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 42 Spain Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 43 Spain Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Japan Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 49 Japan Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Japan Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 51 Japan Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 China Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 53 China Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 54 China Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 55 China Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 India Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 57 India Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 58 India Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 59 India Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 South Korea Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 61 South Korea Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 62 South Korea Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 63 South Korea Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Australia Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 65 Australia Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 66 Australia Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 67 Australia Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 Latin America Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 69 Latin America Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 70 Latin America Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 71 Latin America Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Brazil Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 73 Brazil Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 74 Brazil Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 75 Brazil Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Mexico Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 77 Mexico Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 78 Mexico Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 79 Mexico Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 Argentina Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 81 Argentina Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 82 Argentina Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 83 Argentina Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 85 Middle East & Africa Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 Middle East & Africa Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 87 Middle East & Africa Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 92 South Africa Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 93 South Africa Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 94 South Africa Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 95 South Africa Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 96 UAE Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 97 UAE Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 98 UAE Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 99 UAE Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Rare Diseases Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 5 Global Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 6 Global Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 7 Global Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 8 North America Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 9 North America Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 10 North America Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 11 North America Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 13 U.S. Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 14 U.S. Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 15 U.S. Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Canada Rare Diseases TreatmentMarket, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 17 Canada Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 18 Canada Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 19 Canada Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Europe Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 21 Europe Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 22 Europe Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 23 Europe Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Germany Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 25 Germany Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 26 Germany Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 27 Germany Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 U.K. Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 29 U.K. Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 30 U.K. Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 31 U.K. Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 France Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 33 France Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 34 France Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 35 France Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Italy Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 37 Italy Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 38 Italy Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 39 Italy Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Spain Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 41 Spain Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 42 Spain Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 43 Spain Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Japan Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 49 Japan Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Japan Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 51 Japan Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 China Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 53 China Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 54 China Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 55 China Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 India Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 57 India Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 58 India Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 59 India Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 South Korea Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 61 South Korea Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 62 South Korea Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 63 South Korea Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Australia Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 65 Australia Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 66 Australia Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 67 Australia Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 Latin America Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 69 Latin America Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 70 Latin America Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 71 Latin America Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 Brazil Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 73 Brazil Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 74 Brazil Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 75 Brazil Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Mexico Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 77 Mexico Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 78 Mexico Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 79 Mexico Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 Argentina Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 81 Argentina Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 82 Argentina Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 83 Argentina Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 85 Middle East & Africa Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 Middle East & Africa Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 87 Middle East & Africa Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 92 South Africa Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 93 South Africa Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 94 South Africa Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 95 South Africa Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 96 UAE Rare Diseases Treatment Market, By Therapeutic Area, 2018 - 2030 (USD Million)
Table 97 UAE Rare Diseases Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 98 UAE Rare Diseases Treatment Market, By Drug Type, 2018 - 2030 (USD Million)
Table 99 UAE Rare Diseases Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Rare Diseases Treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Rare diseases treatment market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook, revenue, 2021 (USD Million)
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Rare diseases treatmentmarket driver impact
Fig. 14 Rare diseases treatment market restraint impact
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter’s
Fig. 17 Strategy mapping
Fig. 18 Rare diseases treatment market: Therapeutic Area outlook and key takeaways
Fig. 19 Rare diseases treatment market: Therapeutic Area movement analysis & market share 2021 & 2030
Fig. 20 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Neurological conditions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Musculoskeletal conditions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Hematologic disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Rare diseases treatment market: Route of Administration outlook and key takeaways
Fig. 27 Rare diseases treatment market: Route of Administration movement analysis & market share 2021 & 2030
Fig. 28 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Rare diseases treatment market: Drug Type outlook and key takeaways
Fig. 32 Rare diseases treatment market: Drug Type movement analysis & market share 2021 & 2030
Fig. 33 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Small molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Rare diseases treatmentmarket: Distribution Channel outlook and key takeaways
Fig. 37 Rare diseases treatment market: Distribution Channel movement analysis & market share 2021 & 2030
Fig. 38 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Specialty pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Rare diseases treatment market: Regional outlook and key takeaways
Fig. 42 Regional outlook, 2021 & 2030
Fig. 43 North America
Fig. 44 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 U.S.
Fig. 46 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Canada
Fig. 48 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Europe
Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 U.K.
Fig. 52 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Germany
Fig. 54 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 France
Fig. 56 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Italy
Fig. 58 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Spain
Fig. 60 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Asia Pacific
Fig. 62 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Japan
Fig. 64 Japan market estimates and forecast, 2018 - 2030(USD Million)
Fig. 65 China
Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 India
Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 South Korea
Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Australia
Fig. 72 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Latin America
Fig. 74 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Brazil
Fig. 76 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Mexico
Fig. 78 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Argentina
Fig. 80 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Middle East & Africa
Fig. 82 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 South Africa
Fig. 84 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Saudi Arabia
Fig. 86 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 UAE
Fig. 88 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Market differentiators
Fig. 90 Key company market share analysis, 2021
Fig. 91 Company market position analysis
Fig. 92 Competitive dashboard analysis
Fig. 93 Regional network map
Fig. 1 Rare Diseases Treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Rare diseases treatment market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook, revenue, 2021 (USD Million)
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Rare diseases treatmentmarket driver impact
Fig. 14 Rare diseases treatment market restraint impact
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter’s
Fig. 17 Strategy mapping
Fig. 18 Rare diseases treatment market: Therapeutic Area outlook and key takeaways
Fig. 19 Rare diseases treatment market: Therapeutic Area movement analysis & market share 2021 & 2030
Fig. 20 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Neurological conditions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Musculoskeletal conditions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Hematologic disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Rare diseases treatment market: Route of Administration outlook and key takeaways
Fig. 27 Rare diseases treatment market: Route of Administration movement analysis & market share 2021 & 2030
Fig. 28 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Rare diseases treatment market: Drug Type outlook and key takeaways
Fig. 32 Rare diseases treatment market: Drug Type movement analysis & market share 2021 & 2030
Fig. 33 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Small molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Rare diseases treatmentmarket: Distribution Channel outlook and key takeaways
Fig. 37 Rare diseases treatment market: Distribution Channel movement analysis & market share 2021 & 2030
Fig. 38 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Specialty pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Rare diseases treatment market: Regional outlook and key takeaways
Fig. 42 Regional outlook, 2021 & 2030
Fig. 43 North America
Fig. 44 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 U.S.
Fig. 46 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Canada
Fig. 48 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Europe
Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 U.K.
Fig. 52 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Germany
Fig. 54 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 France
Fig. 56 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Italy
Fig. 58 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Spain
Fig. 60 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Asia Pacific
Fig. 62 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Japan
Fig. 64 Japan market estimates and forecast, 2018 - 2030(USD Million)
Fig. 65 China
Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 India
Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 South Korea
Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Australia
Fig. 72 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Latin America
Fig. 74 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Brazil
Fig. 76 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Mexico
Fig. 78 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Argentina
Fig. 80 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Middle East & Africa
Fig. 82 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 South Africa
Fig. 84 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Saudi Arabia
Fig. 86 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 UAE
Fig. 88 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Market differentiators
Fig. 90 Key company market share analysis, 2021
Fig. 91 Company market position analysis
Fig. 92 Competitive dashboard analysis
Fig. 93 Regional network map
